Skip to main content
Bioscience of Microbiota, Food and Health logoLink to Bioscience of Microbiota, Food and Health
. 2023 Jun 29;43(1):4–12. doi: 10.12938/bmfh.2023-022

Antimicrobial resistance in food-associated Escherichia coli in Mexico and Latin America

Lorena BABINES-OROZCO 1, María Guadalupe BALBUENA-ALONSO 1, Edwin BARRIOS-VILLA 2, Patricia LOZANO-ZARAIN 1, Ygnacio MARTÍNEZ-LAGUNA 1, Rosa DEL CARMEN ROCHA-GRACIA 1,*, Gerardo CORTÉS-CORTÉS 1,3,*
PMCID: PMC10767319  PMID: 38188662

Abstract

The World Health Organization (WHO) considers antimicrobial resistance to be one of the critical global public health priorities to address. Escherichia coli is a commensal bacterium of the gut microbiota in humans and animals; however, some strains cause infections and are resistant to antibiotics. One of the most common ways of acquiring pathogenic E. coli strains is through food. This review analyzes multidrug-resistant E. coli isolated from food, emphasizing Latin America and Mexico, and the mobile genetic elements (MGEs) responsible for spreading antibiotic resistance determinants among bacteria in different environments and hosts. We conducted a systematic search of the literature published from 2015 to 2022 in open access databases and electronic repositories. The prevalence of 11 E. coli pathotypes was described, with diarrheagenic E. coli pathotypes being the most frequently associated with foodborne illness in different Latin American countries, highlighting the presence of different antibiotic resistance genes mostly carried by IncF-type plasmids or class 1 integrons. Although the global incidence of foodborne illness is high, there have been few studies in Mexico and Latin America, which highlights the need to generate updated epidemiological data from the “One Health” approach, which allows monitoring of the multidrug-resistance phenomenon in E. coli from a common perspective in the interaction of human, veterinary, and environmental health.

Keywords: food, Escherichia coli, antimicrobial resistance, Mexico, Latin America

INTRODUCTION

Bacterial resistance to antibiotics has a serious impact on public health, which is why the World Health Organization (WHO) considers it one of the critical priorities to be addressed. Foodborne illnesses are the set of diseases caused by the ingestion of food and/or water containing etiological agents in sufficient quantities to affect the health of the consumer. These diseases are characterized by a wide variety of symptoms, such as diarrhea, vomiting, abdominal pain, headache, nausea, and fever; in some cases, there are severe complications, such as sepsis, meningitis, miscarriage, hemolytic uremic syndrome, Reiter’s syndrome, Guillain–Barré syndrome, or even death [1]. About 250 pathogens have been described that affect humans through contaminated food and beverages. It is estimated that 420,000 people die every year from consuming contaminated food and that 550 million people suffer from diarrheal diseases, of which 230,000 die each year [2]. The etiology of foodborne diseases is varied; viruses, parasites, and bacteria may be involved, with the main agents responsible for mortality being Norovirus, Campylobacter spp, Salmonella enterica, Salmonella Typhi, Taenia solium, Staphylococcus aureus, Clostridium perfringens, Shigella sp, Listeria monocytogenes, hepatitis A virus, and Escherichia coli (mainly O157:H7) [2]. The latter, being part of the intestinal microbiota, is an important indicator of fecal contamination; its detection in the environment is used to monitor the prevalence, types, and movement of resistance genes within and between clinical, agricultural, food, community, and environmental settings [3, 4]. It is estimated that 85% of infections caused by E. coli are transmitted through food by the fecal-oral route, with cattle and the products or by-products obtained from them being one of the main reservoirs that contaminate food and the environment. This contamination happens through the elimination of the pathogen in their feces, spreading between animals by direct contact, through drinking troughs, shared feed, contaminated grazing sites, or other environmental sources [5].

This review aims to provide an update on the involvement of E. coli pathotypes in the development of foodborne diseases as well as the wide range of genetic mechanisms that the bacterium uses to resist the effects of antimicrobials, highlighting the potential for transfer of these determinants through mobile or mobilizable genetic elements. The importance of approaching this phenomenon from the “One Health” point of view, a current approach promoted by the WHO to comprehensively address and contain the spread of the disease, and containing the spread of multidrug-resistant (MDR) bacteria in a comprehensive manner is also discussed.

MATERIALS AND METHODS

A systematic search of the literature was carried out to identify recent bibliographic citations reporting the association of E. coli in the development of foodborne illness as well as the mechanisms of resistance to antibiotics most frequently used to treat infections caused by the bacterium. The search was initially performed in the PubMed database, using the following keywords: “Escherichia coli in foodborne diseases”, “Escherichia coli pathotypes and foodborne diseases”, “Antimicrobial resistance in Escherichia coli”, “Mechanisms of antibiotic resistance in Escherichia coli”, “Horizontal genetic transference of resistance genes in Escherichia coli”, and “Genetic elements carrying antimicrobial resistance genes in Escherichia coli”. In order to obtain studies reported in Mexico and Latin America, we also used the Google Scholar search engine and the following keywords: “Foodborne diseases in Mexico”, “ETA in Mexico”, “Foodborne diseases in Latin America”, “Foodborne diseases in Latin America”, “Escherichia coli isolated from food”, “Escherichia coli isolated from food in Mexico”, “Escherichia coli isolated from food in Latin America”, “Mechanisms of antibiotic resistance in Escherichia coli”, and “Dissemination of antimicrobial resistance in Escherichia coli”. A total of 220 articles were retrieved. The articles were selected based on the following criteria: a) to address epidemiological data on foodborne diseases and their associations with E. coli, b) to describe virulence determinants in diarrheagenic and extraintestinal pathotypes of E. coli, c) to characterize E. coli strains isolated from food, d) to determine antibiotic resistance genes in enterobacteria and E. coli, and e) to describe the mechanisms and elements of genetic material transfer. This review did not generate data that had to be recorded in repositories with an accession number.

RESULTS

A total of 95 articles and 4 electronic repositories from educational and health institutions were included, which were limited to a publication and/or update period from 2015 to 2022.

Pathotypes of E. coli associated with foodborne diseases in Mexico and Latin America

Among the most frequent infections caused by E. coli are enteric and diarrheal diseases. Foodborne diarrheagenic pathotypes of E. coli produce virulence factors (VFs) encoded by several important genes widely reported around the world (Table 1) [6, 7]. The group of diarrheagenic pathotypes is composed of enteropathogenic E. coli (EPEC), Shiga toxin-producing E. coli/enterohemorrhagic E. coli (STEC/EHEC), enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), enterotoxigenic E. coli (ETEC), and diffusely adherent E. coli (DAEC) [6, 8]; STEC, one of the most important pathogens causing foodborne diseases, includes E. coli O157:H7. Serogroups other than O157 (O26, O45, O103, O111, O121, and O145) are known as non-O157 STEC serogroups and are also related to foodborne diseases. Transmission of an STEC causing infections occurs mainly via the consumption or handling of contaminated food, such as raw or undercooked minced meat products, raw milk, raw vegetables, contaminated raw sprouted seeds, and contact with infected animals [6, 9]. However, although the pathotypes mentioned are highly related to foodborne diseases, there are intestinal pathotypes that have shown severe intestinal involvement, such as adherent-invasive E. coli (AIEC). AIEC is a pathotype with particular importance in the last decades due to its frequent presence in patients with Crohn’s disease and ulcerative colitis, which are commonly referred to as inflammatory bowel disease (IBD), and is a relevant pathotype because it is an intestinal bacterium with severe clinical implications [10, 11]. Extraintestinal pathogenic E. coli (ExPEC) diseases can cause a wide variety of infections at multiple anatomic sites. This group includes uropathogenic E. coli (UPEC), neonatal meningitis E. coli (NMEC), sepsis-associated E. coli (SEPEC), avian pathogenic E. coli (APEC), and a potentially emerging ExPEC lineage called endometrial pathogenic E. coli (EnPEC) [12]. ExPEC possess multiple virulence traits and genes (Supplementary Table 1) [12,13,14,15], which allow them to invade and adapt to body sites outside the gastrointestinal tract on any surface, such as food products, especially raw meats [13]. The transmission capacity of ExPEC strains is considered to be of great importance due to the variety of diseases they cause. Neonatal meningitis caused by NMEC strains is one of the most common infections, and it contributes to a neonatal mortality rate of 10% and a morbidity rate of 30% [14]. UPEC is one of the main causes of nosocomial infections and community-acquired urinary tract infections [16]. In Mexico alone, 549,984 cases of urinary tract infections have been reported so far in 2023 [17], with E. coli being the main etiological agent. Although these infections are treatable, the increase in MDR bacteria among ExPEC strains represents a major challenge , as it implies an increase in health care costs and leads to complications, drug treatment failures, as well as higher morbidity and mortality rates [18].

Table 1. Intestinal pathotypes of E. coli and their main virulence factors.

Pathotype Clinical symptoms Host Virulence factor Virulence gene Location References
EHEC/STEC Non-bloody diarrhea, abdominal pain, fever and vomiting Ruminants (bovine), adults, children Shiga toxin stx1, stx2 Phage [6, 7]
Intimin eae Locus LEE
Enterohemolysin E-hly(ehxA) Plasmid
EAEC Watery diarrhea with bloodless mucus Adults, children, travelers to developing countries AAF/I-V (Fimbriae) aggA, aafA, agg3A-5A Plasmid/ Chromosome [6, 7]
Transcriptional Activator aggR
Pet (protease SPATE) pet
EAST1 astA
Mucinase pic
EPEC Acute diarrhea, abdominal pain, vomiting and fever Children <5 years old, adults with high inoculums Bundlin bfpA Plasmid [6, 7]
Intimin eae Locus LEE
Enterohemolysin E-hly(ehxA) Plasmid
ETEC Acute watery diarrhea Children <5 years old, adults, immunocompromised, travelers Heat-stable toxin est Plasmid/ Chromosome [6]
Heat-labile toxin elt
EAST1 asta
EIEC Dysentery Children <5 years old, adults, immunocompromised, travelers Invasin A invA Plasmid INV [6]
Watery diarrhea Antigen H ipaH
DAEC Watery diarrhea without blood Humans Adhesin F1845 daaC Plasmid/ Chromosome [6, 7]

EHEC: enterohemorrhagic E. coli; STEC: Shiga toxin-producing E. coli; EAEC: enteroaggregative E. coli; EPEC: enteropathogenic E. coli; ETEC: enterotoxigenic E. coli; EIEC: enteroinvasive E. coli; DAEC: diffusely adherent E. coli.

In Latin America, at least 77 million people get ill each year from consuming contaminated food, up to 9,000 people die each year, and 10–17 cases per 100,000 are children under 5 years of age who manifest hemorrhagic colitis or sporadic infection with enterotoxin-producing E. coli. Although E. coli is generally considered harmless to humans, certain pathogenic strains can infect the intestinal area and cause severe disease [6]. Studies in different Latin American countries (Table 2) [1, 7, 19,20,21,22] have indicated differences in the prevalence of various pathotypes of E. coli. For example, in Colombia and Nicaragua, most of the reported cases of diarrhea are associated with ETEC, while in Argentina, Mexico, Brazil, Paraguay, and Peru, the most frequent pathotype is EAEC; on the other hand, in Chile, Venezuela, and Uruguay, the main associated pathotype is EPEC [23].

Table 2. Reports of foodborne E. coli in Latin American countries.

Country Finding References
Argentina The STEC pathotype is endemic in Argentina with a prevalence of approximately 500 cases per year and an incidence of 12 to 14 cases per 100,000 in children under five years of age. [19]
Colombia Total prevalence of E. coli of 36.8% (28/76): Meats: 42% (16/38 samples) where 1/16 are STEC and vegetables 31% (12/38 samples) where 1/12 are STEC and 1/12 are EAEC. [1]
Paraguay The frequency of pathotypes in pediatric patients is: 34% ETEC, 22% EAEC, 23% EPEC, 15% EIEC, 4% STEC and 3 2% ETEC/EAEC, 0.5% ETEC/EAEC/EIEC. [20]
Peru In 3,284 E. coli strains isolated from pediatric patients in eight previous studies atypical EPEC (54/74, 73%) was the most frequent pathotype. [21]
Venezuela The frequency of diarrheogenic E. coli is 18.9%, with EPEC being the most frequently isolated pathotype, followed by ETEC and EIEC, while EAEC strains are in last place. [7]
Costa Rica The prevalence of diarrheogenic E. coli is 8.4% corresponding to EPEC. [21]
Mexico The frequency of diarrheogenic strains was 23%; EAEC was the most commonly isolated category, followed by EPEC and ETEC (12.2%, 5.1% and 4.3%, respectively). [22]

STEC: Shiga toxin-producing E. coli; ETEC: enterotoxigenic E. coli; EAEC: enteroaggregative E. coli; EPEC: enteropathogenic E. coli; EIEC: enteroinvasive E. coli; STEC: Shiga toxin-producing E. coli.

Mexico, like many developing countries, experiences a high incidence of foodborne diseases caused by diarrheagenic strains of E. coli found in different foods. These strains show high resistance to first-line antibiotics [22]. In 2017, the General Director of Inocuidad Agroalimentaria, Acuícola y Pesquera del Servicio Nacional de Sanidad e Inocuidad y Calidad Agroalimentaria (SENASICA) reported that 16,000 people die every year due to foodborne diseases in the country [24]. In Mexico, more than 120,000 cases of intestinal infectious diseases have been reported [25], with diarrheal diseases being the second most common cause of morbidity in children under five years of age, with a mortality rate of 27.78 per 100,000 in children under one year of age and 3.47 per 100,000 in children between one and four years of age [26]. E. coli infections are mainly transmitted through food, such as undercooked ground meat, raw milk, salads, leeks, raw potatoes, vegetables, fruits, and other foods [6] often associated with poor hygienic conditions. According to the WHO list of priority antibiotic resistant pathogens published in 2017, E. coli resistant to carbapenems and 3rd generation cephalosporins, as well as extended-spectrum beta-lactamase (ESBL) producers, is among the pathogens of critical priority or first attention, as it has acquired resistance to a high number of antibiotics and can cause severe and often lethal infections [9].

E. coli genome and genetic plasticity

The complete genome of E. coli ranges from 4.6 to 5.9 million base pairs and contains 4,200 to 5,500 genes. The enormous plasticity of its genome has allowed it to adapt to diverse ecological niches, the intestinal environment, and extraintestinal body sites, reflecting the great genetic diversity within the species and causing a wide spectrum of diseases. Unlike other organisms, E. coli has mechanisms to improve its gene pool, such as a) changes in the nucleotide sequence of the genome (mutations), b) genome remodeling through recombination, and c) acquisition of exogenous genes through horizontal gene transfer (HGT). In addition, it is estimated that 10–16% of the E. coli chromosome arose through HGT events, greatly facilitating its genetic flexibility and providing accessory genetic elements, such as those for antibiotic resistance or VFs [27, 28].

Due to the ability that E. coli possesses to exchange genetic material with other bacterial species, it has become an ideal candidate for the study of resistance gene reservoirs in distinct niches [3]. Most E. coli strains enter environments and ecosystems through anthropogenic activities, discharge from livestock and poultry production, hospital and municipal wastewater, or direct contact with livestock, poultry, food-producing animals, and this consequently facilitates the transfer of resistance from non-pathogenic to pathogenic strains in the same environment [4, 5], which makes community and sanitary infections caused by E. coli of greater concern and importance than toxigenic and diarrheal strains with high mortalities in various populations around the world [3].

Study of the easy adaptation, environmental changes, and genomic diversity that characterize E. coli requires the analysis of its genetic environment and the MGEs associated with VFs and antibiotic resistance genes, which could provide helpful information at the epidemiological and medical levels [4].

DISCUSSION

Antimicrobial resistance in E. coli isolated from food in Mexico and Latin America

In recent years, interest in antimicrobial resistance in E. coli isolated from food in Mexico and Latin America has increased not only because of the presence of pathogenic E. coli in food but also because of commensal strains with multidrug resistance worldwide. These commensal strains can act as reservoirs of resistance genes that can be shared with other resident or pathogenic microorganisms in mixed infections and contribute to treatment failure, highlighting the need to implement monitoring and control strategies for these threats [7, 29].

The high frequency of antibiotic-resistant E. coli in food, clinical, community, and environmental settings worldwide has been mainly attributed to the excessive and inappropriate use of antibiotics in human and veterinary medicine. Despite the strategies implemented for the prudent use of antimicrobials, both in livestock production and in the clinical area, for many years, the percentages of MDR bacteria have remained high, representing a constant therapeutic challenge [3, 30, 31]. Furthermore, the appearance of MDR E. coli with high virulence potential is alarming given the risk it represents for human health through the food chain. The increasing evidence of antibiotic resistance genes in diarrheagenic strains (Supplementary Table 2) [32,33,34,35,36,37,38] and ExPEC has seriously complicated the treatment of infections, since the presence of resistance genes in MGEs increases the possibility of spreading antibiotic resistance among STEC bacteria and other bacteria associated with foodborne diseases but also minimizes the possible therapeutic options for human infections [39, 40]. In Mexico, a high rate of resistance to quinolones has been observed in clinical, environmental, diarrheagenic, and pediatric isolates. Multidrug resistance has even been found in UPEC; however, the lack of sufficient data on the virulence spectrum and isolates from community and hospital infections makes infection control and management difficult [16]. Even so, unlike reports on clinical isolates and although the global incidences of foodborne diseases are high, there are few studies on food in Mexico and Latin America, which demonstrates the importance of generating updated data in order to provide useful information to maximize the potential impact of food-borne infections.

Mechanisms of antibiotic resistance in E. coli

Pathogenic strains of E. coli can harbor VFs and antibiotic resistance genes in the same MGEs facilitating their dissemination among isolates, as well as commensal strains that promote the evolution of resistance to different antibiotic families and eventually act as a gene reservoir conferring a high prevalence of resistance genes among foodborne zoonotic pathogens [30, 39, 40]. Pathogenic strains recovered from food and cases of diarrhea and food poisoning come to possess high rates of resistance to groups of commonly used antibiotics, such as quinolones, aminoglycosides, macrolides, cephalosporins, sulfonamides, fluoroquinolones, and tetracycline, with the genes qnr, dfrA1, blaSHV, blaTEM-1, blaCTX-M, tetA, tetB, aac (6)-Ib, sul, cat-1, cmlA, and aadA1 being the most commonly found in diarrheagenic strains, food, water, and some livestock animals, which is why resistance to antibiotics used in animals can be transmissible to humans through contact with or consumption of animal products [32,33,34,35,36].

In Latin America, resistance to beta-lactams is the most reported resistance mechanism, followed by resistance to quinolones [41]. Several studies have shown the presence of ESBL-producing E. coli in food sources such as meat and dairy products [38], as well as β-lactamase AmpC in beef and pork [33, 34]. Although the most commonly found beta-lactamases in E. coli are TEM, SHV, CTX-M, OXA, and NDM [42], studies in Latin America show a high persistence of the blaTEM-1 gene in diarrheagenic strains (Supplementary Table 2). However, genes such as blaCMY, blaSHV, blaOXA, blaCTX-M, blaNDM, and blaTEM-1 have been identified in strains isolated from meat for human consumption and the feces of animals and encoded in different mobilizable genetic elements (Tables 3 and 4) [34, 43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62]. As mentioned above, resistance to quinolones is the second most reported resistance mechanism in Latin America, with aac(6’)-Ib-cr and qnr genes being the most frequently found [41]. However, genes belonging to the chromosomal resistance mechanism, such as gyrA and parC [36], have also been identified in diarrheagenic strains isolated from meat or animals (Supplementary Table 2 and Table 3).

Table 3. Plasmids related to antimicrobial resistance of E. coli reported in Latin American countries.

Plasmid Gene that disseminates Sample origin Study country References
IncF blaCMY, blaSHV, blaOXA-1-like, blaCTX-M tetA, tetB, aac(6′)-Ib, sul2, sul3, aadA, cmlA, qepA, dfr2 Pig feces and soil Brazil [43, 44]
Human Argentina
IncFII  blaCTX-M-15, blaNDM-1 Human Mexico [45]
IncX1 blaCTX-M, sul3, qnrB, dfrA12, cmlA1 Poultry cloacal swabs Cuba [46]
IncFIA blaCTX-M-15, blaCMY, blaSHV, blaOXA-1-like, tetA, tetB, aac(6′)-Ib, aadA, sul1, sul2, sul3, floR, cmlA Pig feces and soil Brazil [44, 47]
Clinical isolate Mexico
IncFIB blaTEM-1 mcr-1, floR, aac(6′)-Ib-cr, aadA1, aadA5,tetA, tetB, cat, qnr,dfrA, sul1, sul2, strA, strB, blaCTX-M-15, blaSHV-12 Clinical isolate Colombia [47, 48]
Mexico
Incl1 blaCTX-M-14, blaTEM-1 Clinical isolate Uruguay [43, 49]
Chicken, beef and pork meat Brazil
IncR blaCTX-M, qnrS,tetA,dfrA14, gyrA, parC, strB Poultry cloacal swabs Cuba [46]
Incl2 mcr-1.5 Human Argentina [43]
IncHI2 blaCTX-M-2, blaTEM-1, sul1, aac(6)-Ib-cr, tetA, tetB, qnrB,dfrA12, gyrA, parC Chicken meat Brazil [43, 46]
Poultry cloacal swabs Cuba
IncX2 qnrB19, tetA Chicken Paraguay [50]
IncA / C blaCMY-2 Cattle, pig, turkey, human, horse Chile [43, 51]
blaNDM-1 Honduras
Colombia
IncN blaCMY, blaSHV, blaOXA-1-like, tetA, tetB, aadA, sul2, qnrB10, aac(6)-Ib-cr Pig feces and soil Brazil [43, 44]
Human Argentina
IncX4 mcr-1 Chicken meat Brazil [52]
Human
Food
ColE-Like qnrB19 Human Peru [43]
Bolivia

Table 4. Integrons, transposons, and insertion sequences associated to antimicrobial resistance genes in E. coli reported in Latin American countries.

Genetic element Rearrangement of genes that disseminate Sample origin Study country References
Integrons
Class 1 and 2 aacA4-catB3-dfrA1, aadA1, dfrA1, aadB, aacC, dfrA17 Chicken Mexico [53, 54]
Clinical isolate
Class 1 and 2 dfrA12-orfF-aadA28, dfrA17-aadA5, dfrA29, aadA7, aadA29, dfrA12-orfF-aadA2-cmlA-aadA1, dfrA1-sat2-aadA30 Canine isolates Brazil [55]
Class 1 and 2 cat1, dfrA1, blaTEM−1, tetA, tetB, aac(6)-Ib Cattle and swine Chile [34]
Class 1 dfrA17, aadA5, sul1, sul2, sul3 Clinical isolate Uruguay [56]
Class 1 aadA1b, aadA2, aadA11cΔ, dfrB3-aadA1di-catB2-aadA6k Biopurification Argentina [53]

Transposons
Tn6242 sul1, mphA, mphR Clinical isolate Mexico [47]
Tn6652 blaCTX-M-14, blaTEM-1 Clinical isolate Uruguay [49]
Tn5387 qnrB19 Human Peru [43]
Bolivia
Tn3000 blaNDM-1 ND Brazil [51]
Tn4401 blaKPC Clinical isolate Argentina, Chile [51, 57, 58]
Brazil
Tn125 and Tn5393 blaNDM-1 ND Colombia [51]
Tn3 mcr -5.3 Horse Brazil [59]

Insertion sequences
ISApl1-IS30 mcr-1 Clinical isolate Colombia [60]
Wild Animal Argentina
Production Animals Mexico
Human Bolivia
IS1 ND Human Argentina [61]
Colombia
IS26 ND Human Argentina [61, 62]
blaCTX-M-8, blaCTX-M-15 Public wastewater treatment plants Brazil
ISEcp1-IS10 blaCTX-M-14 Clinical isolate Uruguay [49]

ND: Not described.

Mechanisms of resistance to antibiotics of last therapeutic resort

Other resistance mechanisms that have been described in E. coli isolates include resistance to fosfomycin caused by mutations in genes of the glpT o uhpA/T transporters [42] and by the inactivation of fosfomycin by fosfomycin-modifying enzymes such as FosA, FosB, FosC, or FosL. The fosA gene and its different subtypes have been found to be associated with plasmids in strains of E. coli and the Enterobacteriaceae family, with the fosA gene being the most commonly found in human and food-producing animal isolates [63].

In addition to fosfomycin resistance, the clinical efficacy of colistin, an antibiotic used as a last resort in the treatment of multidrug-resistant infections, was compromised by the emergence of the plasmid-mediated gene family expressing colistin resistance, comprising the mcr-1 to mcr-9 genes, in the last 4 years [64]. The most worrying characteristics of the mcr genes are their localization in transferable plasmids, because these plasmids facilitate their dissemination by conjugation between different bacterial species, and their constant co-localization with genes encoding ESBL and plasmid AmpC [48, 65]. Currently, the mcr-1 gene has been identified in E. coli isolates in humans and in various foods of animal origin, including meat from chickens, pigs, piglets, cattle, calves, and turkeys [42].

In Latin America, the mcr-1, mcr-3 and mcr-5 genes have been reported in strains isolated from animals, food, and humans, in contrast to other countries, with the mcr-2, mcr-3, mcr-4, mcr-5 genes having been reported in Asian and European countries and the mcr-9 gene having been reported in the USA [66].

Genetic elements involved in the mobilization of resistance genes

As mentioned above, HGT involves the mobilization of genetic elements between bacteria in response to the stress of rapid bacterial adaptation. HGT is one of the main mechanisms responsible for the acquisition of resistance genes and an important factor in bacterial evolution. Elements such as transposons and integrons are involved in intracellular mobility between chromosomes and replicons, while plasmids, bacteriophages, or integrative conjugative elements (ICE) are involved in intercellular gene exchange. According to Latin American reports, plasmids, integrons, transposons, and insertion sequences (ISs) are the main genetic mobilization elements observed in E. coli (Tables 3 and 4). Studies done in other non-Latin American countries (mainly European) also show a wide distribution of resistance determinants in foodborne E. coli around the world (Supplementary Table 3) [3, 4, 50, 53, 63, 65, 67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93].

Plasmids

With a determinant role in the dissemination of antibiotic resistance, plasmids have the capacity to be transmitted horizontally in an autonomous way or can be mobilized. Besides being dispensable when they no longer possess genes indispensable for their host, plasmids that confer multi-resistance are normally large (>50 Kb) and conjugative and possess mechanisms that control the number of plasmid copies, regulating their replication rate [43]. The identification of plasmid characteristics provides important knowledge for understanding the contribution and acquisition of new resistance genes through MGEs as well as their ability to replicate in a wide range of hosts, making them perfect vectors for the propagation of MDR bacteria. Currently, E. coli strains carrying multidrug resistance plasmids are one of the most critical and worrisome antibiotic resistance problems, as they encode resistance to β-lactams, quinolones, aminoglycosides, tetracyclines, sulfonamides, and many other classes of drugs, causing ineffective treatments [28].

Among the most frequently reported plasmids in E. coli of food origin are IncFII, IncFIB, and Incl1 isolated from animals for human consumption, such as chickens and pigs [94]. However, studies in Latin America have reported a great diversity of plasmid groups, such as IncI1, IncFIB, IncFIA, IncFIC, IncHI2, IncQ1, IncFII, IncN, IncR, IncX1, IncX4, IncA/C, IncK, IncP, IncHI1, IncI2, IncColE, and IncY, isolated from food, production animals, pork, chicken meat, and raw vegetables [52, 63].

Integrons

Gene dissemination can also be regulated by integrons capable of integrating and expressing antibiotic resistance genes. Due to variations in the amino acid sequences of their integrases, there are five classes of “mobile” integrons associated with antibiotic resistance: class 1, class 2, class 3, class 4, and class 5 integrons [95]. Class 1 and 2 integrons are frequently detected and well characterized among bacteria belonging to the Enterobacteriaceae family, including E. coli, with the first three classes of integrons being the most involved in the acquisition of the MDR phenotype [96]. Class 1 and 2 integrons have been found in plasmids and transposons, and class 3 integrons have only been found in plasmids and have generally been recovered from clinical contexts; on the other hand, class 4 integrons, or “superintegrons”, and class 5 integrons have minor roles in antibiotic resistance [95].

Studies in different countries around the world have found the presence of integrons in foods such as raw meats, seafood products, fresh vegetables, and fresh fruits, indicating the presence of class 1 integrons as one of the most abundant in strains of E. coli isolated from food products. Class 1 and 2 integrons have been identified in research in the livestock sector and on poultry farms, and class 1, 2, and 3 integrons have been identified in poultry, fruits and vegetables, with the dfrA1 and aadA1 genes being the most reported in food products [53].

In Latin America, class 1 and 2 integrons have been reported (Table 4) with various origins. In Mexico, food of animal origin and fecal samples from domestic animals, humans, and wild animals have been shown to be potential sources of class 1 and 2 integrons [53, 97,98,99]. In Argentina, class 1 integrons have been identified in STEC strains isolated from food, animals, and the agricultural environment [32], and in Chile, class 1 and 2 integrons have been identified in strains of porcine origin [34].

Transposons

Just as plasmids play an important role in the mobilization of genes between cells, transposons, or “jumping genes”, are one of the main mobile elements of dissemination due to their ability to change position within a genome and cause insertional mutations, duplications, and rearrangements in the genome [95].

Because of their self-recombination system, transposons can transfer from one plasmid to other plasmids or from a DNA chromosome to a plasmid and vice versa, causing great variability and giving them the ability to efficiently spread resistance/virulence genes between species, regardless of their level of genetic relatedness [28, 84].

Although most of the reported transposons are of clinical origin, their incidence and spread are potentially dangerous for future or current transmission in food, and this has not yet been sufficiently studied.

Insertion sequences

The insertion sequences are the simplest transposon elements found in prokaryotes, capable of being transposed independently in an organism [90], and play an important role in the evolution and dissemination of antimicrobial resistance genes [60]. However, like transposons, they can be found in chromosomes or plasmids, in addition to having complete or partial promoters, which are frequently located at the ends, allowing them to increase the expression of neighboring genes [51].

The precise search for these elements in different countries showed with greater frequency sequences such as IS26 and ISEcp1 in both Latin American and non-Latin American countries (Table 4 and Supplementary Table 3), related to different origins, but being significant for the prevalence and perspectives formed in each study, giving greater openness to the investigation of elements related to IS, and genes involved with these.

E. coli is one of the bacteria most commonly associated with foodborne diseases due to the ease of contamination of food when harvested or handled under minimal hygienic conditions, as well as the intrinsic capacity of the bacterium to persist and acquire virulence determinants that allow it to cause damage to susceptible hosts. In addition, it has been shown that E. coli pathotypes present high rates of resistance to antibiotics, which limits the therapeutic options to treat infections. In this review, studies reported in the last six years were analyzed to investigate the participation of E. coli in the development of foodborne diseases in Mexico and Latin America. Furthermore, this review concentrated on the contents of genes involved in resistance to different families of antibiotics used in the clinic, with special emphasis on describing those harbored in MGEs such as plasmids, integrons, transposons, and insertion sequences, which facilitate the dissemination of genes among strains of E. coli and other enterobacteria.

Although the global incidence of foodborne diseases is high, few studies have been carried out in Mexico and Latin America, highlighting the need to generate updated and comprehensive epidemiological data with a “One Health” approach to monitor the phenomenon of resistance in E. coli from a common perspective in the interaction of human, veterinary, and environmental health in order to provide more information and minimize the impacts of foodborne infections caused by MDR E. coli. Finally, it is hoped that this literature review will contribute to a better understanding of the current situation regarding the prevalence of antimicrobial resistant E. coli strains in food and their potential risk to human, veterinary, and environmental health.

FUNDING

This work was supported by the Consejo Nacional de Humanidades, Ciencias y Tecnologías (CONAHCYT) [Grant: CB-2017-2018/A1-S-22136]. The CONAHCYT also provided a fellowship [822131 to LBO], and funding source through the Sistema Nacional de Investigadores [87723 to RCRG and 335026 to GCC].

CONFLICT OF INTEREST

The authors declare that they have no conflicts of interest.

Supplementary Material

Supplement Files
bmfh-43-004-s001.pdf (205.8KB, pdf)

Acknowledgments

The authors would like to thank Pepper St. Clair and Sage Chavez from the Department of Biology and Chemistry at California State University Monterey Bay for native English editing.

REFERENCES

  • 1.Soto Z, Pérez L, Estrada D. 2016. Bacterias causantes de enfermedades transmitidas por alimentos: una mirada en Colombia. Revista Salud Uninorte 32: 105–122. [Google Scholar]
  • 2.Zuñiga I, Caro J. 2017. Enfermedades transmitidas por los alimentos: una mirada puntual para el personal de salud. Enfermedades Infecc y Microbiol 37: 95–104. [Google Scholar]
  • 3.Mbelle NM, Feldman C, Osei Sekyere J, Maningi NE, Modipane L, Essack SY. 2019. The resistome, mobilome, virulome and phylogenomics of multidrug-Resistant Escherichia coli clinical isolates from Pretoria, South Africa. Sci Rep 9: 16457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Singh NS, Singhal N, Virdi JS. 2018. Genetic environment of blaTEM-1, blaCTX-M-15, blaCMY-42 and characterization of integrons of Escherichia coli isolated from an Indian urban aquatic environment. Front Microbiol 9: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tabaran A, Soulageon V, Chirila F, Reget OL, Mihaiu M, Borzan M, Dan SD. 2022. Pathogenic E. coli from cattle as a reservoir of resistance genes to various groups of antibiotics. Antibiotics (Basel) 11: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Yang SC, Lin CH, Aljuffali IA, Fang JY. 2017. Current pathogenic Escherichia coli foodborne outbreak cases and therapy development. Arch Microbiol 199: 811–825. [DOI] [PubMed] [Google Scholar]
  • 7.Canata MG, Navarro R, Velázquez G, Rivelli S, Rodríguez F, Céspedes A, Espínola C, Canese J, Guillén R. 2016. Molecular characterization of virulence factors of Escherichia coli isolates obtained from feces of children with gastroenteritis at the Institute for Social Welfare Central Hospital in 2012. Pediatría (Asunción) 43: 13–17. [Google Scholar]
  • 8.de la Rosa-Hernández MC, Cadena-Ramírez A, Téllez-Jurado A, Gómez-Aldapa CA, Rangel-Vargas E, Chávez-Urbiola EA, Castro-Rosas J. 2018. Presence of multidrug-resistant shiga toxin–producing Escherichia coli, enteropathogenic Escherichia coli, and enterotoxigenic Escherichia coli on fresh cheeses from local retail markets in Mexico. J Food Prot 81: 1748–1754. [DOI] [PubMed] [Google Scholar]
  • 9.OMS 2018. E. coli. Available at: https://www.who.int/es/news-room/fact-sheets/detail/e-coli (accessed 2022-05-12).
  • 10.Chervy M, Barnich N, Denizot J. 2020. Adherent-invasive E. coli: Update on the lifestyle of a troublemaker in Crohn’s disease. Int J Mol Sci 21: 1–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Palmela C, Chevarin C, Xu Z, Torres J, Sevrin G, Hirten R, Barnich N, Ng SC, Colombel JF. 2018. Adherent-invasive Escherichia coli in inflammatory bowel disease. Gut 67: 574–587. [DOI] [PubMed] [Google Scholar]
  • 12.Lindstedt BA, Finton MD, Porcellato D, Brandal LT. 2018. High frequency of hybrid Escherichia coli strains with combined Intestinal Pathogenic Escherichia coli (IPEC) and Extraintestinal Pathogenic Escherichia coli (ExPEC) virulence factors isolated from human faecal samples. BMC Infect Dis 18: 544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Mitchell NM, Johnson JR, Johnston B, Curtiss R, 3rd, Mellata M. 2015. Zoonotic potential of Escherichia coli isolates from retail chicken meat products and eggs. Appl Environ Microbiol 81: 1177–1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, Choroszy-Krol I. 2019. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut Pathog 11: 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hayashi W, Tanaka H, Taniguchi Y, Iimura M, Soga E, Kubo R, Matsuo N, Kawamura K, Arakawa Y, Nagano Y, Nagano N. 2019. Acquisition of mcr-1 and cocarriage of virulence genes in avian pathogenic Escherichia coli isolates from municipal wastewater influents in Japan. Appl Environ Microbiol 85: 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ramírez-Castillo FY, Moreno-Flores AC, Avelar-González FJ, Márquez-Díaz F, Harel J, Guerrero-Barrera AL. 2018. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Ann Clin Microbiol Antimicrob 17: 34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Secretaría de Salud 2023. Boletín epidemiológico sistema nacional de vigilancia epidemiológica sistema único de información. Available at: https://www.gob.mx/salud/documentos/boletinepidemiologico-sistema-nacional-de-vigilancia-epidemiologica-sistema-unico-de-informacion-261547 (accessed 2023-03-06)
  • 18.Bonten MJM, Utrecht UMC. 2019. Study to collect information about invasive disease caused by extraintestinal pathogenic Escherichia coli-2 (EXPECT-2). Available at: https://clinicaltrials.gov/ct2/show/study/NCT04117113 (accessed 2022-05-13)
  • 19.Farfán-García AE, Ariza-Rojas SC, Vargas-Cárdenas FA, Vargas-Remolina LV. 2016. Mecanismos de virulencia de Escherichia coli enteropatógena. Rev Chil infectología 33: 438–450. [DOI] [PubMed] [Google Scholar]
  • 20.Weiler N, Orrego M, Alvarez M, Huber C. 2017. Molecular detection of diarrheogenic Escherichia coli in pediatric patients with acute diarrheal syndrome in Paraguay. Memorias del Inst Investig en Ciencias la Salud 15: 16–21. [Google Scholar]
  • 21.Roque M. 2017. Frecuencia de Escherichia coli diarreogenicas aisladas de niños en un hospital pediátrico en Lima-Perú. Cienc Invest 20: 23–28. [Google Scholar]
  • 22.Canizalez-Roman A, Flores-Villaseñor HM, Gonzalez-Nuñez E, Velazquez-Roman J, Vidal JE, Muro-Amador S, Alapizco-Castro G, Díaz-Quiñonez JA, León-Sicairos N. 2016. Surveillance of diarrheagenic Escherichia coli strains isolated from diarrhea cases from children, adults and elderly at northwest of Mexico. Front Microbiol 7: 1924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Molina NB, Oderiz S, Vescina C, Córdoba A, Basualdo JÁ, Sparo MD. 2022. [First report of diarrheagenic Escherichia coli in pediatric outpatient population with diarrhea in La Plata, Argentina]. Rev Argent Microbiol 54: 15–21 (in Spanish). [DOI] [PubMed] [Google Scholar]
  • 24.Global STD. 2017. Enfermedades Transmitidas por Alimentos (ETA). Available at: https://www.globalstd.com/blog/enfermedades-transmitidas-por-alimentos-eta/ (accessed 2022-06-02)
  • 25.Salas-Rosas LM, López CA, Sánchez-Cervantes A, Vázquez-Peláez CG, Rodríguez-Torres A, Cervantes-Chávez JA, Olvera-Ramírez AM. 2020. Prevalence of Salmonella spp. and Escherichia coli O157 in a red deer herd (Cervus elaphus scoticus) in central Mexico. Appl Anim Sci 36: 622–629. [Google Scholar]
  • 26.Ríos-Muñiz D, Cerna-Cortés JF, Morán-García N, Meza-Segura M, Estrada-García T. 2019. Escherichia coli enterotoxigénica y enteroagregativa: prevalencia, patogénesis y modelos múridos. Gac Med Mex 155: 410–416. [DOI] [PubMed] [Google Scholar]
  • 27.Porse A, Gumpert H, Kubicek-Sutherland JZ, Karami N, Adlerberth I, Wold AE, Andersson DI, Sommer MOA. 2017. Genome dynamics of Escherichia coli during antibiotic treatment: transfer, loss, and persistence of genetic elements in situ of the infant gut. Front Cell Infect Microbiol 7: 126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.von Wintersdorff CJH, Penders J, van Niekerk JM, Mills ND, Majumder S, van Alphen LB, Savelkoul PHM, Wolffs PFG. 2016. Dissemination of antimicrobial resistance in microbial ecosystems through horizontal gene transfer. Front Microbiol 7: 173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Amarillas L, Rubí-Rangel L, Chaidez C, González-Robles A, Lightbourn-Rojas L, León-Félix J. 2017. Isolation and characterization of phiLLS, a novel phage with potential biocontrol agent against multidrug-resistant Escherichia coli. Front Microbiol 8: 1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Carvalho I, Chenouf NS, Cunha R, Martins C, Pimenta P, Pereira AR, Martínez-Álvarez S, Ramos S, Silva V, Igrejas G, Torres C, Poeta P. 2021. Antimicrobial resistance genes and diversity of clones among ESBL-and acquired AmpC-producing Escherichia coli isolated from fecal samples of healthy and sick cats in Portugal. Antibiotics (Basel) 10: 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Gambi L, Crippa C, Lucchi A, De Cesare A, Parisi A, Manfreda G, Pasquali F. 2022. Research note: The resistome of commensal Escherichia coli isolated from broiler carcasses “produced without the use of antibiotics”a. Poult Sci 101: 101770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Colello R, Krüger A, Conza JD, Rossen JWA, Friedrich AW, Gutkind G, Etcheverría AI, Padola NL. 2018. Antimicrobial resistance in class 1 integron-positive Shiga toxin-producing Escherichia coli isolated from cattle, pigs, food and farm environment. Microorganisms 6: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Galarce N, Sánchez F, Escobar B, Lapierre L, Cornejo J, Alegría-Morán R, Neira V, Martínez V, Johnson T, Fuentes-Castillo D, Sano E, Lincopan N. 2021. Genomic epidemiology of Shiga toxin-producing Escherichia coli isolated from the livestock-food-human interface in South America. Animals (Basel) 11: 1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Galarce N, Sánchez F, Fuenzalida V, Ramos R, Escobar B, Lapierre L, Paredes-Osses E, Arriagada G, Alegría-Morán R, Lincopán N, Fuentes-Castillo D, Vera-Leiva A, González-Rocha G, Bello-Toledo H, Borie C. 2020. Phenotypic and genotypic antimicrobial resistance in non-O157 Shiga toxin-producing Escherichia coli isolated from cattle and swine in Chile. Front Vet Sci 7: 367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Quino W, Mestanza O, Caro-Castro J, Hurtado CV, Gavilán RG. 2020. Resistome and comparative genomics of clinical isolates of diarrheagenic Escherichia coli from Lima, Peru. Rev Peru Med Exp Salud Publica 37: 705–710. [DOI] [PubMed] [Google Scholar]
  • 36.Guiral E, Gonçalves Quiles M, Muñoz L, Moreno-Morales J, Alejo-Cancho I, Salvador P, Alvarez-Martinez MJ, Marco F, Vila J. 2019. Emergence of resistance to quinolones and β-lactam antibiotics in enteroaggregative and enterotoxigenic Escherichia coli causing traveler’s diarrhea. Antimicrob Agents Chemother 63: 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.de Frutos M, Ramiro R, Pereña JI, Sánchez S. 2020. Mixed infection of four diarrhoeagenic Escherichia coli pathotypes in a case of travellers’ diarrhoea: caracterisation of the isolates by whole-genome sequencing. Enferm Infecc Microbiol Clin (Engl Ed) 38: 39–40 (in Spanish). [DOI] [PubMed] [Google Scholar]
  • 38.Parussolo L, Sfaciotte RAP, Dalmina KA, Melo FD, Da Costa UM, Ferraz SM. 2019. Detection of virulence genes and antimicrobial resistance profiles of Escherichia coli isolates from raw milk and artisanal cheese in Southern Brazil. Semin Agrar 40: 163–178. [Google Scholar]
  • 39.Markland SM, LeStrange KJ, Sharma M, Kniel KE. 2015. Old Friends in new places: exploring the role of extraintestinal E. coli in intestinal disease and foodborne illness. Zoonoses Public Health 62: 491–496. [DOI] [PubMed] [Google Scholar]
  • 40.Mir RA, Kudva IT. 2019. Antibiotic-resistant Shiga toxin-producing Escherichia coli: an overview of prevalence and intervention strategies. Zoonoses Public Health 66: 1–13. [DOI] [PubMed] [Google Scholar]
  • 41.Peñaloza LM, Aspiazu KA. 2021. Mecanismos de resistencia de Escherichia coli en América Latina. Rev Vive 4: 203–216. [Google Scholar]
  • 42.Poirel L, Madec JY, Lupo A, Schink AK, Kieffer N, Nordmann P, Schwarz S. 2018. Antimicrobial resistance in Escherichia coli. Microbiol Spectr 6: 1–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Rozwandowicz M, Brouwer MSM, Fischer J, Wagenaar JA, Gonzalez-Zorn B, Guerra B, Mevius DJ, Hordijk J. 2018. Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae. J Antimicrob Chemother 73: 1121–1137. [DOI] [PubMed] [Google Scholar]
  • 44.Furlan JPR, da Silva Ferreira ME, Stehling EG. 2020. Genetic diversity of multidrug-resistant CMY-producing Escherichia coli from feces and soil in a small-scale pig farm. Microb Drug Resist 26: 1365–1371. [DOI] [PubMed] [Google Scholar]
  • 45.Torres-González P, Bobadilla-Del Valle M, Tovar-Calderón E, Leal-Vega F, Hernández-Cruz A, Martínez-Gamboa A, Niembro-Ortega MD, Sifuentes-Osornio J, Ponce-de-León A. 2015. Outbreak caused by Enterobacteriaceae harboring NDM-1 metallo-β-lactamase carried in an IncFII plasmid in a tertiary care hospital in Mexico City. Antimicrob Agents Chemother 59: 7080–7083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Baez M, Espinosa I, Collaud A, Miranda I, Montano DLN, Feria AL, Hernández-Fillor RE, Obregón D, Alfonso P, Perreten V. 2021. Genetic features of extended-spectrum β-lactamase-producing Escherichia coli from poultry in mayabeque province, Cuba. Antibiotics (Basel) 10: 1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Barrios-Camacho H, Duran-Bedolla J, Silva-Sanchez J, Lozano-Aguirre L, Reyna-Flores F, Sanchez-Perez A, Graza-Ramos U. 2021. Genetic characterization of plasmid-mediated qepA gene among ESBL- producing Escherichia coli isolates in Mexico. Res Sq 1–7. Available at: (accessed 2022-06-17). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Saavedra SY, Diaz L, Wiesner M, Correa A, Arévalo SA, Reyes J, Hidalgo AM, de la Cadena E, Perenguez M, Montaño LA, Ardila J, Ríos R, Ovalle MV, Díaz P, Porras P, Villegas MV, Arias CA, Beltrán M, Duarte C. 2017. Genomic and molecular characterization of clinical isolates of Enterobacteriaceae harboring mcr-1 in Colombia, 2002 to 2016. Antimicrob Agents Chemother 61: 1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Di Pilato V, Papa-Ezdra R, Chiarelli A, García-Fulgueiras V, Pallecchi L, Vignoli R. 2019. Characterization of the first blaCTX-M-14/ermB-carrying IncI1 plasmid from Latin America. Plasmid 102: 1–5. [DOI] [PubMed] [Google Scholar]
  • 50.Dobiasova H, Dolejska M. 2016. Prevalence and diversity of IncX plasmids carrying fluoroquinolone and β-lactam resistance genes in Escherichia coli originating from diverse sources and geographical areas. J Antimicrob Chemother 71: 2118–2124. [DOI] [PubMed] [Google Scholar]
  • 51.Reyes JA, Melano R, Cárdenas PA, Trueba G. 2020. Mobile genetic elements associated with carbapenemase genes in South American Enterobacterales. Braz J Infect Dis 24: 231–238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Mendes Oliveira VR, Paiva MC, Lima WG. 2019. Plasmid-mediated colistin resistance in Latin America and Caribbean: a systematic review. Travel Med Infect Dis 31: 101459. [DOI] [PubMed] [Google Scholar]
  • 53.Zhang S, Abbas M, Rehman MU, Huang Y, Zhou R, Gong S, Yang H, Chen S, Wang M, Cheng A. 2020. Dissemination of antibiotic resistance genes (ARGs) via integrons in Escherichia coli: a risk to human health. Environ Pollut 266: 115260. [DOI] [PubMed] [Google Scholar]
  • 54.Ochoa SA, Cruz-Córdova A, Luna-Pineda VM, Reyes-Grajeda JP, Cázares-Domínguez V, Escalona G, Sepúlveda-González ME, López-Montiel F, Arellano-Galindo J, López-Martínez B, Parra-Ortega I, Giono-Cerezo S, Hernández-Castro R, de la Rosa-Zamboni D, Xicohtencatl-Cortes J. 2016. Multidrug- and extensively drug-resistant uropathogenic Escherichia coli clinical strains: phylogenetic groups widely associated with integrons maintain high genetic diversity. Front Microbiol 7: 2042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Siqueira AK, Michael GB, Domingos DF, Ferraz MMG, Ribeiro MG, Schwarz S, Leite DS. 2016. Diversity of class 1 and 2 integrons detected in Escherichia coli isolates from diseased and apparently healthy dogs. Vet Microbiol 194: 79–83. [DOI] [PubMed] [Google Scholar]
  • 56.Poey ME, Laviña M. 2018. Horizontal transfer of class 1 integrons from uropathogenic Escherichia coli to E. coli K12. Microb Pathog 117: 16–22. [DOI] [PubMed] [Google Scholar]
  • 57.Vera-Leiva A, Barría-Loaiza C, Carrasco-Anabalón S, Lima C, Aguayo-Reyes A, Domínguez M, Bello-Toledo H, González-Rocha G. 2017. KPC: Klebsiella pneumoniae carbapenemase, main carbapenemase in Enterobacteriaceae. Rev Chilena Infectol 34: 476–484. [DOI] [PubMed] [Google Scholar]
  • 58.De Belder D, Lucero C, Rapoport M, Rosato A, Faccone D, Petroni A, Pasteran F, Albornoz E, Corso A, Gomez SA. 2018. Genetic diversity of KPC-producing Escherichia coli, Klebsiella oxytoca, Serratia marcescens, and Citrobacter freundii isolates from Argentina. Microb Drug Resist 24: 958–965. [DOI] [PubMed] [Google Scholar]
  • 59.Fernandes MR, Cerdeira L, Silva MM, Sellera FP, Muñoz M, Junior FG, Azevedo SS, Power P, Gutkind G, Lincopan N. 2018. Novel mcr-5.3 variant in a CTX-M-8-producing Escherichia coli ST711 isolated from an infected horse. J Antimicrob Chemother 73: 3520–3522. [DOI] [PubMed] [Google Scholar]
  • 60.Lentz SAM, Dalmolin TV, Barth AL, Martins AF. 2021. mcr-1 gene in Latin America: how is it disseminated among humans, animals, and the environment? Front Public Health 9: 648940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Reid CJ, McKinnon J, Djordjevic SP. 2019. Clonal ST131-H22 Escherichia coli strains from a healthy pig and a human urinary tract infection carry highly similar resistance and virulence plasmids. Microb Genom 5: 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Dropa M, Lincopan N, Balsalobre LC, Oliveira DE, Moura RA, Fernandes MR, da Silva QM, Matté GR, Sato MIZ, Matté MH. 2016. Genetic background of novel sequence types of CTX-M-8- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae from public wastewater treatment plants in São Paulo, Brazil. Environ Sci Pollut Res Int 23: 4953–4958. [DOI] [PubMed] [Google Scholar]
  • 63.Huang Y, Lin Q, Zhou Q, Lv L, Wan M, Gao X, Wang C, Liu JH. 2020. Identification of fosA10, a novel plasmid-mediated fosfomycin resistance gene of Klebsiella pneumoniae origin, in Escherichia coli. Infect Drug Resist 13: 1273–1279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Ling Z, Yin W, Shen Z, Wang Y, Shen J, Walsh TR. 2020. Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9. J Antimicrob Chemother 75: 3087–3095. [DOI] [PubMed] [Google Scholar]
  • 65.Ragupathi NKD, Bakthavatchalam YD, Mathur P, Pragasam AK, Walia K, Ohri VC, Veeraraghavan B. 2019. Plasmid profiles among some ESKAPE pathogens in a tertiary care centre in south India. Indian J Med Res 149: 222–231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Elbediwi M, Li Y, Paudyal N, Pan H, Li X, Xie S, Rajkovic A, Feng Y, Fang W, Rankin SC, Yue M. 2019. Global burden of colistin-resistant bacteria: mobilized colistin resistance genes study (1980–2018). Microorganisms 7: 1–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Belotindos LP, Tsunoda R, Villanueva MA, Nakajima C, Mingala CN, Suzuki Y. 2022. Characterisation of plasmids harbouring qnrA1, qnrS1, and qnrB4 in E. coli isolated in the Philippines from food-producing animals and their products. J Glob Antimicrob Resist 30: 38–46. [DOI] [PubMed] [Google Scholar]
  • 68.Dunn SJ, Connor C, McNally A. 2019. The evolution and transmission of multi-drug resistant Escherichia coli and Klebsiella pneumoniae: the complexity of clones and plasmids. Curr Opin Microbiol 51: 51–56. [DOI] [PubMed] [Google Scholar]
  • 69.Lyimo B, Buza J, Subbiah M, Temba S, Kipasika H, Smith W, Call DR. 2016. IncF plasmids are commonly carried by antibiotic resistant Escherichia coli isolated from drinking water sources in northern Tanzania. Int J Microbiol 2016: 3103672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Yang QE, Sun J, Li L, Deng H, Liu BT, Fang LX, Liao XP, Liu YH. 2015. IncF plasmid diversity in multi-drug resistant Escherichia coli strains from animals in China. Front Microbiol 6: 964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Gajendiran R, Daniel JLK, Walia K, Veeraraghavan B. 2017. First Indian report of IncX3 plasmid carrying blaNDM-7 in Escherichia coli from bloodstream infection: potential for rapid dissemination. New Microbes New Infect 17: 65–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Jeong S, Kim JO, Yoon EJ, Bae IK, Lee W, Lee H, Park Y, Lee K, Jeong SH. 2018. Extensively drug-resistant Escherichia coli sequence type 1642 carrying an IncX3 plasmid containing the blaKPC-2 Gene associated with transposon Tn4401a. Ann Lab Med 38: 17–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Pitart C, Solé M, Roca I, Román A, Moreno A, Vila J, Marco F. 2015. Molecular characterization of blaNDM-5 carried on an IncFII plasmid in an Escherichia coli isolate from a nontraveler patient in Spain. Antimicrob Agents Chemother 59: 659–662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Alousi S, Salloum T, Arabaghian H, Matar GM, Araj GF, Tokajian ST. 2018. Genomic characterization of MDR Escherichia coli harboring blaOXA-48 on the IncL/M-type plasmid isolated from blood stream infection. BioMed Res Int 2018: 3036143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Tyson GH, Li C, Hsu CH, Bodeis-Jones S, McDermott PF. 2019. Diverse fluoroquinolone resistance plasmids from retail meat E. coli in the United States. Front Microbiol 10: 2826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Fang L, Li X, Li L, Li S, Liao X, Sun J, Liu Y. 2016. Co-spread of metal and antibiotic resistance within ST3-IncHI2 plasmids from E. coli isolates of food-producing animals. Sci Rep 6: 25312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Sun YW, Liu YY, Wu H, Wang LF, Liu JH, Yuan L, Pan YS, He DD, Hu GZ. 2019. IS26-flanked composite transposon Tn6539 carrying the tet(M) gene in IncHI2-type conjugative plasmids from Escherichia coli isolated from ducks in China. Front Microbiol 9: 3168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Harmer CJ, Hall RM. 2015. The A to Z of A/C plasmids. Plasmid 80: 63–82. [DOI] [PubMed] [Google Scholar]
  • 79.Kotlarska E, Łuczkiewicz A, Pisowacka M, Burzyński A. 2015. Antibiotic resistance and prevalence of class 1 and 2 integrons in Escherichia coli isolated from two wastewater treatment plants, and their receiving waters (Gulf of Gdansk, Baltic Sea, Poland). Environ Sci Pollut Res Int 22: 2018–2030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Sunde M, Simonsen GS, Slettemeås JS, Böckerman I, Norström M. 2015. Integron, plasmid and host strain characteristics of Escherichia coli from humans and food included in the Norwegian antimicrobial resistance monitoring programs. PLoS One 10: e0128797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Kheiri R, Akhtari L. 2016. Antimicrobial resistance and integron gene cassette arrays in commensal Escherichia coli from human and animal sources in IRI. Gut Pathog 8: 40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Wyrsch ER, Roy Chowdhury P, Chapman TA, Charles IG, Hammond JM, Djordjevic SP. 2016. Genomic microbial epidemiology is needed to comprehend the global problem of antibiotic resistance and to improve pathogen diagnosis. Front Microbiol 7: 843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Cho S, Nguyen HAT, McDonald JM, Woodley TA, Hiott LM, Barrett JB, Jackson CR, Frye JG. 2019. Genetic characterization of antimicrobial-resistant Escherichia coli isolated from a mixed-use watershed in northeast Georgia, USA. Int J Environ Res Public Health 16: 1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Babakhani S, Oloomi M. 2018. Transposons: the agents of antibiotic resistance in bacteria. J Basic Microbiol 58: 905–917. [DOI] [PubMed] [Google Scholar]
  • 85.McKinnon J, Roy Chowdhury P, Djordjevic SP. 2018. Genomic analysis of multidrug-resistant Escherichia coli ST58 causing urosepsis. Int J Antimicrob Agents 52: 430–435. [DOI] [PubMed] [Google Scholar]
  • 86.Chowdhury PR, McKinnon J, Liu M, Djordjevic SP. 2019. Multidrug resistant uropathogenic Escherichia coli ST405 with a novel, composite IS26 transposon in a unique chromosomal location. Front Microbiol 10: 1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.de Toro M, Fernández J, García V, Mora A, Blanco J, de la Cruz F, Rodicio MR. 2017. Whole genome sequencing, molecular typing and in vivo virulence of OXA-48-producing Escherichia coli isolates including ST131 H30-Rx, H22 and H41 subclones. Sci Rep 7: 12103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Ho PL, Ng KY, Lo WU, Law PY, Lai EL, Wang Y, Chow KH. 2015. Plasmid-mediated OqxAB is an important mechanism for nitrofurantoin resistance in Escherichia coli. Antimicrob Agents Chemother 60: 537–543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Chowdhury PR, Charles IG, Djordjevic SP. 2015. A role for Tn6029 in the evolution of the complex antibiotic resistance gene loci in genomic island 3 in enteroaggregative hemorrhagic Escherichia coli O104:H4. PLoS One 10: 1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Song HJ, Moon DC, Mechesso AF, Kang HY, Kim MH, Choi JH, Kim SJ, Yoon SS, Lim SK. 2020. Resistance profiling and molecular characterization of extended-spectrum/plasmid-mediated ampc β-lactamase-producing Escherichia coli isolated from healthy broiler chickens in South Korea. Microorganisms 8: 1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Li W, Yan Y, Chen J, Sun R, Wang Y, Wang T, Feng Z, Peng K, Wang J, Chen S, Luo Y, Li R, Yang B. 2021. Genomic characterization of conjugative plasmids carrying the mcr-1 gene in foodborne and clinical strains of Salmonella and Escherichia coli. Food Control 125: 1–13. [Google Scholar]
  • 92.Hamamoto K, Tokunaga T, Yagi N, Hirai I. 2020. Characterization of blaCTX-M-14 transposition from plasmid to chromosome in Escherichia coli experimental strain. Int J Med Microbiol 310: 151395. [DOI] [PubMed] [Google Scholar]
  • 93.Reid CJ, Wyrsch ER, Roy Chowdhury P, Zingali T, Liu M, Darling AE, Chapman TA, Djordjevic SP. 2017. Porcine commensal Escherichia coli: a reservoir for class 1 integrons associated with IS26. Microb Genom 3: 1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Salinas L, Cárdenas P, Johnson TJ, Vasco K, Graham J, Trueba G. 2019. Diverse commensal E. coli clones and plasmids disseminate antimicrobial resistance genes in domestic animals and children in a semi-rural community in Ecuador. MSphere 4: 1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Troncoso C, Pavez M, Santos A, Salazar R, Barrientos Díaz L. 2017. Structural and physiological implications of bacterial cell in antibiotic resistance mechanisms. Int J Morphol 35: 1214–1223. [Google Scholar]
  • 96.Racewicz P, Majewski M, Biesiada H, Nowaczewski S, Wilczyński J, Wystalska D, Kubiak M, Pszczoła M, Madeja ZE. 2022. Prevalence and characterisation of antimicrobial resistance genes and class 1 and 2 integrons in multiresistant Escherichia coli isolated from poultry production. Sci Rep 12: 6062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Rocha-Gracia RC, Cortés-Cortés G, Lozano-Zarain P, Bello F, Martínez-Laguna Y, Torres C. 2015. Faecal Escherichia coli isolates from healthy dogs harbour CTX-M-15 and CMY-2 β-lactamases. Vet J 203: 315–319. [DOI] [PubMed] [Google Scholar]
  • 98.Cortés-Cortés G, Lozano-Zarain P, Torres C, Castañeda M, Sánchez GM, Alonso CA, López-Pliego L, Mayen MG, Martínez-Laguna Y, Rocha-Gracia RC. 2016. Detection and molecular characterization of Escherichia coli strains producers of extended-spectrum and CMY-2 type beta-lactamases, isolated from turtles in Mexico. Vector Borne Zoonotic Dis 16: 595–603. [DOI] [PubMed] [Google Scholar]
  • 99.Barrios-Villa E, Cortés-Cortés G, Lozano P, Romero-Romero S, Lara N, Estepa V, Somalo S, Torres C, Rocha-Gracia R C. 2018. Characterization of extended-spectrum and CMY-2 β-lactamases, and associated virulence genes in Escherichia coli from food of animal origin in México. Br Food J 120: 1457–1473. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement Files
bmfh-43-004-s001.pdf (205.8KB, pdf)

Articles from Bioscience of Microbiota, Food and Health are provided here courtesy of IPEC, Inc.

RESOURCES